Physician profile
Karen E Tobin
NPI 1396707683
$2,725.49
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,191 · 2020: $488 · 2023: $29.52 · 2024: $17.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $507.98 | 2019-2020 | |
| Ucb, INC. | $214.59 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $197.75 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $185.45 | 2019-2020 | |
| Allergan, INC. | $148.45 | 2019 | |
| Sunovion Pharmaceuticals INC. | $146.39 | 2019-2020 | |
| Amgen INC. | $109.34 | 2019-2020 | |
| Genzyme Corporation | $100.55 | 2019 | |
| Acorda Therapeutics, INC | $90.32 | 2019-2020 | |
| Biogen, INC. | $84.82 | 2019-2020 | |
| Genentech USA, INC. | $79.34 | 2019-2020 | |
| Tersera Therapeutics LLC | $75.52 | 2019 | |
| Emd Serono, INC. | $75.15 | 2019 | |
| Acadia Pharmaceuticals INC | $63.77 | 2019 | |
| Vertical Pharmaceuticals, LLC | $60.38 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $58.15 | 2019 | |
| Assertio Therapeutics, INC. | $58.06 | 2019 | |
| Adamas Pharmaceuticals, INC. | $55.54 | 2019 | |
| Amneal Pharmaceuticals LLC | $51.93 | 2019-2020 | |
| Catalyst Pharmaceuticals, INC. | $36.89 | 2019 | |
| Lilly USA, LLC | $36.30 | 2019-2020 | |
| Sk Life Science, INC. | $34.69 | 2020 | |
| Lundbeck LLC | $29.83 | 2019 | |
| Medline Industries Lp | $29.52 | 2023 | |
| Abbott Laboratories | $25.96 | 2019-2020 | |
| Ge Healthcare | $25.56 | 2019 | |
| Portola Pharmaceuticals, LLC | $24.63 | 2019 | |
| Neurocrine Biosciences, INC. | $20.75 | 2020 | |
| Tanabe Pharma America, INC. | $19.17 | 2020 | |
| Jazz Pharmaceuticals INC. | $17.92 | 2019 | |
| Boston Scientific Corporation | $17.07 | 2024 | |
| Currax Pharmaceuticals LLC | $15.42 | 2020 | |
| Mdd US Operations, LLC | $15.29 | 2020 | |
| Avanir Pharmaceuticals, INC. | $13.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Tobin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.